在ARDS患者中,ECMO二次的严重高胆红素血症:一个病例报告
Yamin Gao1, Wei Wang1, Yuchen Duan1
1Department of Critical Care Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Frontiers in medicine
|February 26, 2026
概括
本案例研究详细介绍了一名患有严重流感A型肺炎的患者,该患者的肺炎通过静脉静脉外体膜氧化 (VV-ECMO) 得到治疗. 患者出现了免疫介导的血液溶解和高白血症,并通过多式疗法成功治疗.
科学领域:
- 临界护理医学 临界护理医学
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
背景情况:
- 严重的甲型流感病毒感染可能导致急性呼吸困扰综合征,需要先进的生命支持.
- 静脉静脉外体膜氧化 (VV-ECMO) 是耐火性低氧症的一个关键干预措施.
- 接受VV-ECMO治疗的患者可能会出现并发症,如高白血和血液溶解.
研究的目的:
- 在接受VV-ECMO的患者中报告严重的超白血病与免疫媒介血解的病例.
- 突出ECMO期间分辨出血解类型的诊断挑战.
- 为了证明ECMO相关的高白血症的联合治疗策略的有效性.
主要方法:
- 高通量测序用于流感A病毒的识别.
- 胸部CT用于肺炎和肺的评估.
- 在严重呼吸衰竭的情况下启动VV-ECMO.
- 使用肝脏保护剂,双等离子体分子吸附系统 (DPMAS) 和治疗性等离子体交换来治疗高白血症.
- 免疫血液学测试以确认免疫介导的血液溶解.
主要成果:
- 成功的VV-ECMO支持严重流感A诱导的呼吸衰竭.
- 在ECMO期间出现严重的混合高白血症,具有显著的溶血成分.
- 通过阳性抗球蛋白测试确认免疫介导的血液溶解.
- 在多式治疗后,胆红素水平的正常化和成功的ECMO脱.
- 从机械通风和医院出院中成功断奶.
结论:
- 在ECMO患者中,区分机械和免疫媒介血解至关重要.
- 涉及DPMAS和血交换的综合治疗方法可以有效地管理严重的ECMO相关的高白血症.
- 这一案例强调了警监测和针对ECMO重症患者的量身定制干预的重要性.
相关概念视频
Acute Respiratory Failure-IV
623
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
623
Acute Respiratory Failure-I
1.2K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.2K
Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-V
552
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
552
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
680
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
680


